for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Solasia Pharma KK

4597.T

Latest Trade

151.00JPY

Change

-3.00(-1.95%)

Volume

721,700

Today's Range

150.00

 - 

154.00

52 Week Range

118.00

 - 

248.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
154.00
Open
153.00
Volume
721,700
3M AVG Volume
14.25
Today's High
154.00
Today's Low
150.00
52 Week High
248.00
52 Week Low
118.00
Shares Out (MIL)
105.13
Market Cap (MIL)
16,239.42
Forward P/E
--
Dividend (Yield %)
--

Next Event

Dividend For 4597.T - 0.0000 JPY

Latest Developments

More

Solasia Pharma says new share prices

Solasia Pharma to issue new shares to raise up to 4.34 bln yen

Solasia Pharma KK says announcement concerning signing of license and distribution agreement for SP-02

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Solasia Pharma KK

Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System (Sancuso), SP-02 Darinaparsin (Zinapar, ZIO-101, and SP-03 Oral Medical Device (episil oral liquid).

Industry

Biotechnology & Drugs

Contact Info

3F, Shiodome Bldg., 1-2-20, Kaigan

+81.3.58438045

https://www.sios.com/company/

Executive Leadership

Yoshihiro Arai

President, Representative Director

Toshio Miyashita

Chief Financial Officer, Chief Director of Administration, Director

Norikazu Eiki

Independent Director

Tajio Enoki

Independent Director

Stanley Lau

Independent Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
44.61
Price To Book (MRQ)
2.70
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
1.37
LT Debt To Equity (MRQ)
0.68
Return on Investment (TTM)
-45.32
Return on Equity (TTM)
-42.01

Latest News

Latest News

BRIEF-Solasia Pharma says termination of clinical trials phase 1 of SP-04

* Says it announces termination of SP-04 clinical trials phase 1, for treatment of peripheral nerves disability

BRIEF-Pledpharma and Solasia enter license agreement on Pledox in Asia

* PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA

BRIEF- Solasia Pharma to sign distributorship agreement with ITOCHU

* Says it plans to sign a distributorship agreement with ITOCHU Corp, regarding sales of the company's products in China (except Hong Kong and Macau )

BRIEF- Solasia Pharma announces approval of episil® oral liquid in Japan

* Says it obtained the marketing approval of episil®(SP-03), in Japan, on July 6

BRIEF- JapanBridge (Ireland) cuts voting power in Solasia Pharma KK to 19.7 pct

* Says JapanBridge (Ireland) Limited cut voting power in the company to 19.7 percent from 24 percent

BRIEF- JapanBridge (Ireland) to cut voting power in Solasia Pharma KK to 7.9 pct

* Says its second biggest shareholder JapanBridge (Ireland) Limited will cut voting power in the company to 7.9 percent from 24 percent

BRIEF-Solasia Pharma to raise 496.2 mln yen in shares private placement

* Says the co to issue new shares via private placement and raise 496.2 million yen, with subscription date on April 24 and payment date on April 25

BRIEF-Solasia Pharma says listing on TSE Mothers

* Says its stock began listing on Tokyo Stock Exchange (TSE) Mothers on March 24

BRIEF-Solasia Pharma KK announces IPO on TSE Mothers on March 24

* Says its stock will begin trading on the Tokyo Stock Exchange (TSE) Mothers on March 24, 2017, under the symbol "4597"

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up